Legal Representation
Attorney
Jeff Goehring
USPTO Deadlines 1 active
Deadline Type | Event Code | Deadline Date | Days Until | Priority | Extension Available |
---|---|---|---|---|---|
MAINTENANCE
Section 8 & 9 (20-Year) Renewal Due (Based on registration date 2009-06-16) |
R.PRA | Jun 16, 2029 | 1440 days | Critical | No |
Next deadline: Section 8 & 9 (20-Year) Renewal Due (Based on registration date 2009-06-16)
on June 16, 2029
(1440 days)
Application History
50 eventsDate | Code | Type | Description |
---|---|---|---|
Aug 23, 2022 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
Aug 23, 2022 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
Aug 23, 2022 | ECDR | I | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS |
Aug 23, 2022 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
Sep 29, 2020 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
Sep 29, 2020 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
Sep 29, 2020 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
Sep 29, 2020 | ECDR | I | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS |
Sep 29, 2020 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
Sep 29, 2020 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
Sep 21, 2020 | 8PRT | O | REGISTERED - PARTIAL SEC. 8 (10-YR) ACCEPTED |
Sep 21, 2020 | 9G8P | O | REGISTERED - SEC. 9 GRANTED/CHECK RECORD FOR SEC. 8 |
Sep 21, 2020 | RNL1 | Q | REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) |
Sep 21, 2020 | NAS8 | E | NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED |
Sep 18, 2020 | PCGR | O | PETITION TO DIRECTOR GRANTED |
Aug 27, 2020 | APET | A | ASSIGNED TO PETITION STAFF |
Jul 13, 2020 | TPDR | I | TEAS PETITION TO DIRECTOR RECEIVED |
Jan 11, 2020 | PR89 | O | POST REGISTRATION ACTION MAILED - SEC. 8 & 9 |
Nov 22, 2019 | EROP | I | TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED |
Oct 13, 2019 | PR89 | O | POST REGISTRATION ACTION MAILED - SEC. 8 & 9 |
Sep 26, 2019 | EROP | I | TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED |
Sep 25, 2019 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
Sep 25, 2019 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
Jun 3, 2019 | PR89 | O | POST REGISTRATION ACTION MAILED - SEC. 8 & 9 |
May 22, 2019 | APRE | A | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
May 16, 2019 | E89R | I | TEAS SECTION 8 & 9 RECEIVED |
Jun 16, 2018 | REM2 | E | COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED |
Aug 3, 2015 | CORV | 6 | REVIEW OF CORRESPONDENCE COMPLETE - INFORMATION MADE OF RECORD |
Jul 30, 2015 | EWAF | I | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS |
May 16, 2015 | APRE | A | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
May 16, 2015 | 8.OK | O | REGISTERED - SEC. 8 (6-YR) ACCEPTED |
May 16, 2015 | NAS8 | E | NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED |
May 12, 2015 | ES8R | I | TEAS SECTION 8 RECEIVED |
Nov 19, 2014 | ASGN | I | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
Jan 4, 2014 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
Jan 4, 2014 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
Jun 16, 2009 | R.PR | A | REGISTERED-PRINCIPAL REGISTER |
Mar 31, 2009 | PUBO | A | PUBLISHED FOR OPPOSITION |
Mar 11, 2009 | NPUB | O | NOTICE OF PUBLICATION |
Feb 24, 2009 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED |
Feb 23, 2009 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER |
Feb 3, 2009 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
Feb 2, 2009 | ERSI | I | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED |
Feb 2, 2009 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Jan 27, 2009 | RCSC | S | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED |
Jan 22, 2009 | RCCK | S | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION |
Jul 22, 2008 | CNSL | S | LETTER OF SUSPENSION MAILED |
Jul 21, 2008 | CNSL | R | SUSPENSION LETTER WRITTEN |
Jul 4, 2008 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
Jul 3, 2008 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Detailed Classifications
Class 005
[ Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical antitussive-cold preparations; Pharmaceutical anti-allergic preparations and substances; Pharmaceutical for the treatment of erectile dysfunction; Pharmaceutical preparations, namely, anticoagulants; Pharmaceutical preparations, namely, antidepressants; Pharmaceutical preparations, namely, appetite suppressants; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparation for the treatment of gout; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; Pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; Pharmaceutical preparations for treating allergic rhinitis and asthma; Pharmaceutical preparations for treating diabetes; Pharmaceutical sedative preparations; Pharmaceutical preparations for use in urology; Yeast or yeast extracts for medical or pharmaceutical purposes; Pharmaceutical products for ophthalmologic use; Pharmaceutical preparations for wounds; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for human skincare; Anti-diabetic pharmaceuticals; Pharmaceutical antiseptic preparations; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; Pharmaceutical preparations, namely, a drug delivery system comprising oral alcoholic liquid for per lingual release of a wide variety of therapeutic agents; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Unit dose capsules sold empty for pharmaceutical use ]
First Use Anywhere:
0
First Use in Commerce:
0
Class 010
[ Aerosol dispensers for medical use; Dropper bottles for administering medication, sold empty; Droppers for administering medication, sold empty; Drug delivery systems; Unit does bottles and capsules for per lingual delivering medication ]
First Use Anywhere:
0
First Use in Commerce:
0
Class 042
Conducting early evaluations in the field of new pharmaceuticals; Development of pharmaceutical preparations and medicines; Pharmaceutical product evaluation; Pharmaceutical research and development; Research and development of pharmaceutical capsules for pharmaceutical use
First Use Anywhere:
0
First Use in Commerce:
0
Active Deadlines
Section 8 & 9 (20-Year) Renewal Due (Based on registration date 2009-06-16)
Due: Jun 16, 2029
Grace Period Until: Dec 16, 2029
Additional Information
Design Mark
The mark consists of a light blue-green stylized hand with palm facing up catching a yellow star above the hand with a light blue-green curved line trailing the yellow star.
Color Claim
The color(s) yellow and light blue-green is/are claimed as a feature of the mark.
Classification
International Classes
005
010
042